COLLEGE GROVE, TN
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NEURONEXUS IS A PUBLIC NAME FOR THE NOVEL PHARMACEUTICS INSTITUTE, A 501 (C)3 CHARITABLE ORGANIZATION FOR THESE PURPOSES: PROVIDE A PUBLIC FORUM AND MEDICAL EDUCATION AND RESEARCH SPECIFICALLY FOCUSED ON NEUROSCIENCES. PRINCIPLE GOALS ARE TO ENHANCE THE LOCAL AND REGIONAL ACCESS OF STUDENTS TO NEUROSCIENCE EXPERTISE, PROVIDE EXPERTISE TO THE PHARMACEUTICAL INDUSTRY, AND SUPPORT LOCAL RESEARCH MISSIONS FOR TREATMENT AND DIAGNOSIS OF NEUROLOGICAL DISEASE.
MEDICAL EDUCATION, CONTINUING EDUCATION GRANTS, MEDICAL RESEARCH, TRAINING PHYSICIANS IN USE OF MEDICATION, PUBLIC INFORMATION, PUBLIC EDUCATION ON NEUROLOGICAL DISEASE, GRANTS FOR CONTINUING...
MEDICAL EDUCATION, CONTINUING EDUCATION GRANTS, MEDICAL RESEARCH, TRAINING PHYSICIANS IN USE OF MEDICATION, PUBLIC INFORMATION, PUBLIC EDUCATION ON NEUROLOGICAL DISEASE, GRANTS FOR CONTINUING EDUCATION AND EXPOSURE TO EDUCATION OPPORTUNITIES FOR STUDENTS, EDUCATIONAL BENEFITS FOR STUDENTS, TRAINING FOR MEDICAL RELATED STUDENT ACTIVITY, INTERNSHIPS, MENTORSHIPS AND TRAINING FOR INDIVIDUALS, YOUTHS AND STUDENTS IN HEALTH CARE PROFESSIONS. DR. DANIEL KANTOR, CHAIRMAN OF THE BOARD, OPERATES THE AFFILIATED GROUP, MEDICAL PARTNERSHIP FOR MS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | N/A | N/A | N/A |
| Expenses | $2,672 | $21,326 | -0.9% |
| Net Income | N/A | $-21,326 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| AMY BROWN | SECRETARY | 0.10 |
Officer
Director
|
$0 | $0 | $0 |
| DR DANIEL KANTOR | CHAIRMAN | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| RANDOLPH QUIGLEY | BOARD MEMBER | 0.10 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2023 | No data | $2,672 | $14,305 | No data |
| 2022 | No data | $21,326 | $16,977 | No data |
| 2021 | $7,129 | $12,330 | $38,303 | $-5,201 |
| 2020 | $31,530 | $34,892 | $42,859 | $-3,362 |
| 2019 | $60,850 | $316,600 | $32,201 | $-255,750 |
| 2018 | $34,969 | $108,639 | $286,576 | $-73,670 |
Compare NEURONEXUS with other nonprofits in Tennessee and across the country.